These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25886078)

  • 21. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.
    El-Laithy HM; Nesseem DI; El-Adly AA; Shoukry M
    Arch Pharm Res; 2011 Oct; 34(10):1663-78. PubMed ID: 22076767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
    Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Campa M; Senesi S
    J Ocul Pharmacol Ther; 2013; 29(6):586-90. PubMed ID: 23428175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sodium sulfapyridazine in new delayed-action bases for the treatment of bacterial conjunctivitis].
    Maĭchuk IuF; Pozdniakov VI; Kur'iazov IK; Moldaver BL; Rusak AV
    Antibiot Khimioter; 1991 Apr; 36(4):26-8. PubMed ID: 1892429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ophthalmic preservatives: focus on polyquaternium-1.
    Rolando M; Crider JY; Kahook MY
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antibacterial activity of levofloxacin eye drops against staphylococci using an in vitro pharmacokinetic model in the bulbar conjunctiva.
    Suzuki T; Yamamoto T; Ohashi Y
    J Infect Chemother; 2016 Jun; 22(6):360-5. PubMed ID: 27036073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular delivery systems of pefloxacin mesylate.
    Bharath S; Hiremath SR
    Pharmazie; 1999 Jan; 54(1):55-8. PubMed ID: 9987797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.
    Khalil RM; Abdelbary GA; Basha M; Awad GE; El-Hashemy HA
    J Liposome Res; 2017 Jun; 27(2):118-129. PubMed ID: 27079800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of levofloxacin loaded
    Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z
    Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system.
    Deshmukh PK; Gattani SG
    Pharm Dev Technol; 2013; 18(4):950-6. PubMed ID: 22200332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
    Cao F; Zhang X; Ping Q
    Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
    Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
    Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
    Srividya B; Cardoza RM; Amin PD
    J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
    Lihong W; Xin C; Yongxue G; Yiying B; Gang C
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
    Sayed EG; Hussein AK; Khaled KA; Ahmed OA
    Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
    Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
    Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels.
    Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D
    Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.